Breaking News Instant updates and real-time market news.

CLOV

Clover Health

$16.97 /

-5.07 (-23.00%)

08:53
06/10/21
06/10
08:53
06/10/21
08:53

Clover Health enters preferred provider relationship with Upward Health

Upward Health announced a new preferred provider relationship with Clover Health to serve patients with medical, behavioral, and social challenges through Clover's in-home primary care program, Clover Home Care. The effort was launched shortly after Clover was identified as a participant in CMS' new direct contracting initiative, which is designed to improve healthcare quality and contain costs for beneficiaries with Original Medicare. As Clover scales Clover Home Care through direct contracting, the company has contracted with Upward Health to provide integrated home-based medical and behavioral care for aligned beneficiaries with needs in the States of New York, Pennsylvania, Georgia and Texas.

CLOV Clover Health
$16.97 /

-5.07 (-23.00%)

06/10/21 BofA
Clover Health downgraded to Underperform from Neutral at BofA
05/18/21 Citi
Clover Health price target lowered to $10 from $13 at Citi
05/17/21 BofA
Clover Health downgraded to Neutral at BofA after guidance cut
05/17/21 BofA
Clover Health downgraded to Neutral from Buy at BofA

TODAY'S FREE FLY STORIES

Upgrade
West Japan Railway upgraded to Buy from Neutral at Mizuho » 05:14
06/14/21
06/14
05:14
06/14/21
05:14
WJRYY

West Japan Railway

$62.33 /

-1.185 (-1.87%)

Mizuho analyst Katsuhiko…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WJRYY West Japan Railway
$62.33 /

-1.185 (-1.87%)

12/04/20 JPMorgan
West Japan Railway upgraded to Overweight from Neutral at JPMorgan
09/17/20 Jefferies
West Japan Railway downgraded to Hold from Buy at Jefferies
08/06/20 Mizuho
West Japan Railway downgraded to Neutral from Buy at Mizuho
06/17/20 Morgan Stanley
West Japan Railway downgraded to Underweight from Overweight at Morgan Stanley
Downgrade
Pernod Ricard downgraded to Market Perform from Outperform at Bernstein » 05:13
06/14/21
06/14
05:13
06/14/21
05:13
PDRDY

Pernod Ricard

$43.41 /

-0.4841 (-1.10%)

Bernstein analyst Trevor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PDRDY Pernod Ricard
$43.41 /

-0.4841 (-1.10%)

04/26/21 JPMorgan
Pernod Ricard price target raised to EUR 190 from EUR 160 at JPMorgan
04/23/21 Barclays
Pernod Ricard price target raised to EUR 197 from EUR 195 at Barclays
04/23/21 Morgan Stanley
Pernod Ricard price target raised to EUR 187 from EUR 182 at Morgan Stanley
04/23/21 Credit Suisse
Pernod Ricard price target raised to EUR 183 from EUR 172 at Credit Suisse
Downgrade
Diageo downgraded to Market Perform from Outperform at Bernstein » 05:13
06/14/21
06/14
05:13
06/14/21
05:13
DEO

Diageo

$194.38 /

-0.67 (-0.34%)

Bernstein analyst Trevor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DEO Diageo
$194.38 /

-0.67 (-0.34%)

DEO Diageo
$194.38 /

-0.67 (-0.34%)

06/04/21 Argus
Diageo upgraded to Buy from Hold at Argus
06/04/21 Argus
Diageo upgraded to Buy from Hold at Argus
05/14/21 Berenberg
Diageo price target raised to 3,540 GBp from 3,250 GBp at Berenberg
05/13/21 Deutsche Bank
Diageo price target raised to 4,200 GBp from 4,000 GBp at Deutsche Bank
Downgrade
Davide Campari-Milano downgraded to Market Perform from Outperform at Bernstein » 05:12
06/14/21
06/14
05:12
06/14/21
05:12
DVDCF

Davide Campari-Milano

$13.53 /

+ (+0.00%)

Bernstein analyst Trevor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVDCF Davide Campari-Milano
$13.53 /

+ (+0.00%)

05/06/21 Berenberg
Davide Campari-Milano price target raised to EUR 11.90 at Berenberg
05/06/21 Morgan Stanley
Davide Campari-Milano price target raised to EUR 9.50 at Morgan Stanley
05/06/21 Societe Generale
Davide Campari-Milano price target raised to EUR 12 at Societe Generale
05/05/21 Credit Suisse
Davide Campari-Milano price target raised to EUR 9.20 from EUR 9 at Credit Suisse
Downgrade
Remy Cointreau downgraded to Underperform from Market Perform at Bernstein » 05:11
06/14/21
06/14
05:11
06/14/21
05:11
REMYY

Remy Cointreau

$20.54 /

-0.19 (-0.92%)

Bernstein analyst Trevor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REMYY Remy Cointreau
$20.54 /

-0.19 (-0.92%)

06/09/21 Goldman Sachs
Remy Cointreau upgraded to Buy from Neutral at Goldman Sachs
06/04/21 Deutsche Bank
Remy Cointreau price target raised to EUR 204 from EUR 196 at Deutsche Bank
06/04/21 JPMorgan
Remy Cointreau price target lowered to EUR 165 from EUR 167 at JPMorgan
06/04/21 Barclays
Remy Cointreau price target lowered to EUR 166 from EUR 172 at Barclays
Hot Stocks
Sasol receives Competition Tribunal approval for divestment of ASUs » 05:08
06/14/21
06/14
05:08
06/14/21
05:08
SSL

Sasol

$16.88 /

-0.45 (-2.60%)

On September 10 2020, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSL Sasol
$16.88 /

-0.45 (-2.60%)

SSL Sasol
$16.88 /

-0.45 (-2.60%)

04/13/21 Morgan Stanley
Sasol upgraded to Overweight from Equal Weight at Morgan Stanley
Downgrade
Kajima downgraded to Underweight from Equal Weight at Morgan Stanley » 05:08
06/14/21
06/14
05:08
06/14/21
05:08
KAJMY

Kajima

$13.54 /

-0.29 (-2.10%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KAJMY Kajima
$13.54 /

-0.29 (-2.10%)

10/21/20 Mizuho
Kajima downgraded to Neutral from Buy at Mizuho
09/10/20 SMBC Nikko
Kajima downgraded to Neutral from Outperform at SMBC Nikko
06/19/20 Daiwa
Kajima upgraded to Outperform from Neutral at Daiwa
Upgrade
Taisei upgraded to Equal Weight from Underweight at Morgan Stanley » 05:07
06/14/21
06/14
05:07
06/14/21
05:07
TISCF

Taisei

$37.10 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TISCF Taisei
$37.10 /

+ (+0.00%)

06/24/20 Daiwa
Taisei downgraded to Neutral from Outperform at Daiwa
Downgrade
Shimizu downgraded to Equal Weight from Overweight at Morgan Stanley » 05:07
06/14/21
06/14
05:07
06/14/21
05:07
SHMUY

Shimizu

$34.27 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHMUY Shimizu
$34.27 /

+ (+0.00%)

03/10/21 Daiwa
Shimizu upgraded to Outperform from Neutral at Daiwa
09/10/20 SMBC Nikko
Shimizu upgraded to Outperform from Neutral at SMBC Nikko
09/01/20 Morgan Stanley
Shimizu upgraded to Equal Weight from Underweight at Morgan Stanley
Downgrade
Ipsen downgraded to Hold from Buy at Societe Generale » 05:06
06/14/21
06/14
05:06
06/14/21
05:06
IPSEY

Ipsen

$27.85 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IPSEY Ipsen
$27.85 /

+ (+0.00%)

IPSEY Ipsen
$27.85 /

+ (+0.00%)

05/28/21 Barclays
Ipsen price target raised to EUR 92 from EUR 89 at Barclays
05/27/21 JPMorgan
Ipsen price target raised to EUR 95 from EUR 85 at JPMorgan
04/23/21 Societe Generale
Ipsen price target lowered to EUR 93 from EUR 94 at Societe Generale
04/20/21 Deutsche Bank
Ipsen initiated with a Hold at Deutsche Bank
Initiation
Oatly Group initiated with a Neutral at Exane BNP Paribas » 05:05
06/14/21
06/14
05:05
06/14/21
05:05
OTLY

Oatly Group

$28.71 /

+2.01 (+7.53%)

Exane BNP Paribas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 20
    May
OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

General news
European stock markets are broadly higher, » 05:05
06/14/21
06/14
05:05
06/14/21
05:05
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Initiation
Neighbourly Pharmacy initiated with a Buy at Industrial Alliance » 05:04
06/14/21
06/14
05:04
06/14/21
05:04
NBLY.TO

Neighbourly Pharmacy

/

+

Industrial Alliance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NBLY.TO Neighbourly Pharmacy
/

+

04:51 Today BMO Capital
Neighbourly Pharmacy initiated with a Market Perform at BMO Capital
Recommendations
AlloVir remains a top small-cap pick at Piper Sandler » 04:58
06/14/21
06/14
04:58
06/14/21
04:58
ALVR

AlloVir

$22.07 /

+0.21 (+0.96%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALVR AlloVir
$22.07 /

+0.21 (+0.96%)

ALVR AlloVir
$22.07 /

+0.21 (+0.96%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/22/21 Piper Sandler
AlloVir remains a top 2021 pick at Piper Sandler
02/11/21 Piper Sandler
AlloVir price target raised to $55 from $52 at Piper Sandler
08/24/20 Piper Sandler
AlloVir initiated with an Overweight at Piper Sandler
ALVR AlloVir
$22.07 /

+0.21 (+0.96%)

  • 30
    Jul
Recommendations
ViewRay shares should attract more investor interest, says Piper Sandler » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
VRAY

ViewRay

$5.80 /

+0.05 (+0.87%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

05/07/21 Guggenheim
ViewRay upgraded to Buy from Neutral at Guggenheim
03/26/21 BTIG
ViewRay upgraded to Buy from Neutral at BTIG
01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
01/04/21 Piper Sandler
Piper Sandler remains 'positively inclined' on ViewRay after preliminary results
VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

Conference/Events
Cornerstone OnDemand participates in a conference call with Benchmark » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
CSOD

Cornerstone OnDemand

$50.98 /

+0.08 (+0.16%)

Analyst Schappel holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSOD Cornerstone OnDemand
$50.98 /

+0.08 (+0.16%)

CSOD Cornerstone OnDemand
$50.98 /

+0.08 (+0.16%)

05/07/21 BMO Capital
Cornerstone OnDemand price target lowered to $50 from $63 at BMO Capital
04/27/21 JMP Securities
Workday price target raised to $310 from $296 at JMP Securities
03/26/21 DA Davidson
DA Davidson sees 'material' COVID tailwinds for Cornerstone OnDemand
02/17/21 BMO Capital
Cornerstone OnDemand price target raised to $63 from $47 at BMO Capital
CSOD Cornerstone OnDemand
$50.98 /

+0.08 (+0.16%)

CSOD Cornerstone OnDemand
$50.98 /

+0.08 (+0.16%)

Conference/Events
OncoCyte management to meet virtually with BTIG » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
OCX

OncoCyte

$5.45 /

+0.225 (+4.31%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

04/12/21 Lake Street
AACR data strengthens 'pan-cancer credentials' for OncoCyte, says Lake Street
04/12/21 Piper Sandler
OncoCyte remains a top pick small-cap pick at Piper Sandler
03/30/21 Piper Sandler
OncoCyte called 'top small-cap pick' at Piper Sandler
03/17/21
Fly Intel: Top five analyst initiations
OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

  • 05
    Feb
OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

Conference/Events
Gain Therapeutics management to meet virtually with Oppenheimer » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
GANX

Gain Therapeutics

$10.13 /

-0.02 (-0.20%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GANX Gain Therapeutics
$10.13 /

-0.02 (-0.20%)

GANX Gain Therapeutics
$10.13 /

-0.02 (-0.20%)

04/12/21 Oppenheimer
Gain Therapeutics initiated with an Outperform at Oppenheimer
04/12/21 Oppenheimer
Gain Therapeutics initiated with an Outperform at Oppenheimer
04/12/21 BTIG
Gain Therapeutics initiated with a Buy at BTIG
  • 18
    Mar
GANX Gain Therapeutics
$10.13 /

-0.02 (-0.20%)

Conference/Events
Snowflake management to meet virtually with Oppenheimer » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
SNOW

Snowflake

$240.83 /

-7.96 (-3.20%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNOW Snowflake
$240.83 /

-7.96 (-3.20%)

SNOW Snowflake
$240.83 /

-7.96 (-3.20%)

06/11/21 Morgan Stanley
Morgan Stanley says 'unprecedented' Snowflake forecast may still be conservative
06/11/21 JMP Securities
Snowflake target model calls for $10B in revenue by FY29, says JMP Securities
06/11/21 Piper Sandler
Snowflake price target lowered to $290 from $312 at Piper Sandler
06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
SNOW Snowflake
$240.83 /

-7.96 (-3.20%)

  • 16
    Mar
  • 16
    Sep
SNOW Snowflake
$240.83 /

-7.96 (-3.20%)

SNOW Snowflake
$240.83 /

-7.96 (-3.20%)

Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call » 04:55
06/14/21
06/14
04:55
06/14/21
04:55

Retail/Broadlines &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
APTO

Aptose Biosciences

$3.75 /

-1.79 (-32.31%)

, MBIO

Mustang Bio

$3.79 /

-0.03 (-0.79%)

, QURE

uniQure

$36.05 /

-0.63 (-1.72%)

, RIGL

Rigel Pharmaceuticals

$4.02 /

-0.16 (-3.83%)

, MGTA

Magenta Therapeutics

$11.57 /

-0.15 (-1.28%)

, MEIP

MEI Pharma

$3.28 /

+0.08 (+2.50%)

, CRIS

Curis

$8.00 /

-4.72 (-37.11%)

, XLRN

Acceleron

$133.36 /

+2.36 (+1.80%)

, EPZM

Epizyme

$8.53 /

+0.08 (+0.95%)

, INCY

Incyte

$82.59 /

-4.97 (-5.68%)

, ORTX

Orchard Therapeutics

$5.12 /

-0.05 (-0.97%)

, TGTX

TG Therapeutics

$37.81 /

-0.14 (-0.37%)

, EQ

Equillium

$6.12 /

-0.85 (-12.20%)

, JAZZ

Jazz Pharmaceuticals

$186.19 /

-0.21 (-0.11%)

, VRTX

Vertex Pharmaceuticals

$193.02 /

-23.93 (-11.03%)

, SGEN

Seagen

$156.27 /

-2.3 (-1.45%)

, IMRA

Imara

$8.56 /

-0.235 (-2.67%)

, GBT

Global Blood Therapeutics

$40.64 /

-1.01 (-2.42%)

, BGNE

BeiGene

$346.81 /

-6.09 (-1.73%)

, APLS

Apellis

$62.10 /

+1.33 (+2.19%)

, AGIO

Agios Pharmaceuticals

$57.80 /

-1.69 (-2.84%)

, FMTX

Forma Therapeutics

$22.81 /

-5.2 (-18.56%)

, KROS

Keros Therapeutics

$51.75 /

-0.61 (-1.17%)

, CYAD

Celyad

$5.75 /

-0.22 (-3.69%)

, ALXN

Alexion

$181.64 /

-0.41 (-0.23%)

EHA 2021 Virtual Congress…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

CYAD Celyad
$5.75 /

-0.22 (-3.69%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley Securities
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.05 /

-0.63 (-1.72%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 SunTrust
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.00 /

-4.72 (-37.11%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.59 /

-4.97 (-5.68%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.12 /

-0.85 (-12.20%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 Stifel
Vertex shares look 'cheap' at aftermarket levels, says Stifel
SGEN Seagen
$156.27 /

-2.3 (-1.45%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.56 /

-0.235 (-2.67%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$62.10 /

+1.33 (+2.19%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.75 /

-0.22 (-3.69%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.64 /

-0.41 (-0.23%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

  • 15
    Dec
  • 11
    Dec
  • 09
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

Conference/Events
Jefferies aerospace/defense analysts to hold analyst/industry conference call » 04:55
06/14/21
06/14
04:55
06/14/21
04:55

Aerospace & Defense…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Jefferies aerospace/defense analysts to hold analyst/industry conference call » 04:55
06/14/21
06/14
04:55
06/14/21
04:55

Aerospace & Defense…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
BioVie management to meet virtually with B. Riley » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
BIVI

BioVie

$17.99 /

+3.09 (+20.74%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIVI BioVie
$17.99 /

+3.09 (+20.74%)

BIVI BioVie
$17.99 /

+3.09 (+20.74%)

05/25/21 B. Riley
BioVie price target raised to $50 from $47 at B. Riley
01/15/21 B. Riley Securities
B. Riley starts 'largely overlooked' BioVie with Buy, $47 target
01/15/21 B. Riley Securities
BioVie initiated with a Buy at B. Riley Securities
Conference/Events
Cantor biotech/biopharma analysts hold an analyst/industry conference call » 04:55
06/14/21
06/14
04:55
06/14/21
04:55

Biotech Analyst Young and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.